TRCT
IPSC icon

Tower Research Capital (TRC)’s Century Therapeutics IPSC Stock Holding History

Tower Research Capital (TRC)’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$74.6K Buy
+32,987
New +$69.4K ﹤0.01% 2414
2025
Q4 		– Sell
-13,116
Closed -$6.53K – 5373
2025
Q3 		$6.53K Sell
13,116
-9,246
-41% -$4.99K ﹤0.01% 4155
2025
Q2 		$12.5K Buy
22,362
+4,854
+28% +$2.6K ﹤0.01% 3884
2025
Q1 		$8.33K Buy
17,508
+7,699
+78% +$5.78K ﹤0.01% 3900
2024
Q4 		$9.91K Buy
9,809
+2,709
+38% +$3.69K ﹤0.01% 3863
2024
Q3 		$12.1K Sell
7,100
-9,932
-58% -$19.5K ﹤0.01% 3615
2024
Q2 		$43.4K Buy
17,032
+12,676
+291% +$40.1K ﹤0.01% 3209
2024
Q1 		$18.2K Buy
4,356
+406
+10% +$1.72K ﹤0.01% 3080
2023
Q4 		$13.1K Sell
3,950
-23,901
-86% -$43.5K ﹤0.01% 3982
2023
Q3 		$55.7K Buy
27,851
+24,879
+837% +$66.2K ﹤0.01% 2454
2023
Q2 		$9.39K Buy
2,972
+760
+34% +$2.45K ﹤0.01% 4291
2023
Q1 		$8K Sell
2,212
-6,740
-75% -$29.6K ﹤0.01% 4636
2022
Q4 		$46K Buy
8,952
+4,795
+115% +$45.3K ﹤0.01% 2409
2022
Q3 		$41K Buy
4,157
+904
+28% +$9.52K ﹤0.01% 3336
2022
Q2 		$27K Buy
3,253
+2,459
+310% +$24.1K ﹤0.01% 3472
2022
Q1 		$10K Sell
794
-2,271
-74% -$30.1K ﹤0.01% 4316
2021
Q4 		$49K Buy
3,065
+2,468
+413% +$46.4K ﹤0.01% 2771
2021
Q3 		$15K Buy
+597
New +$16.2K ﹤0.01% 3979

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Tower Research Capital (TRC)'s IPSC Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in Century Therapeutics (IPSC) in Q1 2026: 32,987 shares worth $74.6K. The stake represents ﹤0.01% of the portfolio and ranks #2414 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in IPSC as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in IPSC in Q3 2021 and has held it in 18 quarters since. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Tower Research Capital (TRC) held 32,987 shares of Century Therapeutics worth $74.6K as of Q1 2026.
  • Century Therapeutics was a new Tower Research Capital (TRC) position in Q1 2026.
  • Century Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2414 holding.
  • Tower Research Capital (TRC) first reported a position in Century Therapeutics in Q3 2021 and has held it in 18 quarters since.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.